Found: 6
Select item for more details and to access through your institution.
Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 622, doi. 10.1007/s10637-022-01235-5
- By:
- Publication type:
- Article
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2009, v. 2, p. 21
- By:
- Publication type:
- Article
Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2499, doi. 10.3390/cancers14102499
- By:
- Publication type:
- Article
The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5206, doi. 10.3390/cancers13205206
- By:
- Publication type:
- Article
A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib: Evaluating for a T790M Mutation With Limited Tissue.
- Published in:
- Oncology (08909091), 2018, v. 32, n. 10, p. 499
- By:
- Publication type:
- Article
Phase II Study of Topotecan and Bevacizumab in Advanced, Refractory Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2013, v. 14, n. 5, p. 495, doi. 10.1016/j.cllc.2013.04.009
- By:
- Publication type:
- Article